Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02288130Phase 4Unknown
Phase 4, randomised, double-blind trial of ulipristal in Uterine Fibroids (UF) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Blood loss during surgery. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02288130.